Yu J - Search Results

1

Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study.

Wang Z, Yu XL, Zhang J, Cheng ZG, Han ZY, Liu FY, Dou JP, Kong Y, Dong XJ, Zhao QX, Yu J, Liang P, Tang WZ. Wang Z, et al. Among authors: yu xl, yu j. J Ethnopharmacol. 2021 Dec 5;281:114539. doi: 10.1016/j.jep.2021.114539. Epub 2021 Aug 21. J Ethnopharmacol. 2021. PMID: 34428522 Free article.

2

Cholecystectomy is associated with higher risk of recurrence after microwave ablation of hepatocellular carcinoma: a propensity score matching analysis.

Yang H, Yang Y, Dou J, Cui R, Cheng Z, Han Z, Liu F, Yu X, Zhou X, Yu J, Liang P. Yang H, et al. Among authors: yu x, yu j. Cancer Biol Med. 2020 May 15;17(2):478-491. doi: 10.20892/j.issn.2095-3941.2019.0246. Cancer Biol Med. 2020. PMID: 32587783 Free PMC article.

3

Efficacy and safety of percutaneous ultrasound-guided microwave ablation for cervical metastatic lymph nodes from papillary thyroid carcinoma.

Han ZY, Dou JP, Cheng ZG, Liu FY, Yu J, Yu XL, Liang P. Han ZY, et al. Among authors: yu xl, yu j. Int J Hyperthermia. 2020;37(1):971-975. doi: 10.1080/02656736.2020.1805128. Int J Hyperthermia. 2020. PMID: 32781871 Free article.

4

Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.

Li X, Chen B, An C, Cheng Z, Han Z, Liu F, Yu J, Liang P. Li X, et al. Among authors: yu j. J Cancer Res Ther. 2020 Sep;16(5):1027-1037. doi: 10.4103/jcrt.JCRT_380_19. J Cancer Res Ther. 2020. PMID: 33004744 Free article.

5

Predictive effects of a combined indicator in patients with hepatocellular carcinoma after thermal ablation.

Yang Q, Yu XL, Wang Y, Cheng ZG, Han ZY, Liu FY, Qian TG, Yu J, Liang P. Yang Q, et al. Among authors: yu xl, yu j. J Cancer Res Ther. 2020 Sep;16(5):1038-1050. doi: 10.4103/jcrt.JCRT_1080_19. J Cancer Res Ther. 2020. PMID: 33004745 Free article.

6

Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.

An C, Li WZ, Huang ZM, Yu XL, Han YZ, Liu FY, Wu SS, Yu J, Liang P, Huang J. An C, et al. Among authors: yu xl, yu j. Eur Radiol. 2021 Jul;31(7):4764-4773. doi: 10.1007/s00330-020-07571-5. Epub 2021 Jan 5. Eur Radiol. 2021. PMID: 33399908 Free PMC article.

7

Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma: A real-world single-center study.

Ding W, Yu J, Liu F, Yu X, Cheng Z, Han Z, Liang P. Ding W, et al. Among authors: yu x, yu j. Dig Liver Dis. 2022 Feb;54(2):243-250. doi: 10.1016/j.dld.2021.04.008. Epub 2021 Jul 7. Dig Liver Dis. 2022. PMID: 34244109

8

BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation.

Li X, Guo M, Yang L, Cheng Z, Yu X, Han Z, Liu F, Sun Q, Han X, Yu J, Liang P. Li X, et al. Among authors: yu x, yu j. J Cancer Res Ther. 2021 Jul;17(3):644-651. doi: 10.4103/jcrt.JCRT_1504_20. J Cancer Res Ther. 2021. PMID: 34269294 Free article.

9

Colonic metastasis from hepatocellular carcinoma after treated by ablation and transarterial chemoembolization manifested by intestinal obstruction: A case report and review of the literature.

Mu M, Yu J, Liang P, Yu X, Cheng Z. Mu M, et al. Among authors: yu x, yu j. J Cancer Res Ther. 2021 Jul;17(3):814-817. doi: 10.4103/jcrt.JCRT_217_20. J Cancer Res Ther. 2021. PMID: 34269320 Free article. Review.

10

Percutaneous thermal ablation versus open liver resection for recurrent hepatoblastoma: a retrospective study.

Chen ST, Han ZY, Ling P, Yu XL, Cheng ZG, Liu FY, Jiang H, Yu J. Chen ST, et al. Among authors: yu xl, yu j. Int J Hyperthermia. 2021;38(1):1086-1091. doi: 10.1080/02656736.2021.1941310. Int J Hyperthermia. 2021. PMID: 34286633 Free article.

11

Dynamic changes in liver volume calculated using a three-dimensional visualisation system after microwave ablation of hepatocellular carcinomas.

Dong L, Cheng Z, Liu F, Yu X, Han Z, Luo Y, Xu H, Chen R, Huang C, Yu J, Liang P. Dong L, et al. Among authors: yu x, yu j. Med Phys. 2022 Jul;49(7):4613-4621. doi: 10.1002/mp.15641. Epub 2022 Apr 28. Med Phys. 2022. PMID: 35366342

12

Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation.

Wu JP, Ding WZ, Wang YL, Liu S, Zhang XQ, Yang Q, Cai WJ, Yu XL, Liu FY, Kong D, Zhong H, Yu J, Liang P. Wu JP, et al. Among authors: yu xl, yu j. Int J Hyperthermia. 2022;39(1):595-604. doi: 10.1080/02656736.2022.2062463. Int J Hyperthermia. 2022. PMID: 35435082 Free article. Clinical Trial.

13

Multiparametric liver MRI for predicting early recurrence of hepatocellular carcinoma after microwave ablation.

Zhang Z, Yu J, Liu S, Dong L, Liu T, Wang H, Han Z, Zhang X, Liang P. Zhang Z, et al. Among authors: yu j. Cancer Imaging. 2022 Aug 30;22(1):42. doi: 10.1186/s40644-022-00471-5. Cancer Imaging. 2022. PMID: 36042507 Free PMC article.

14

Percutaneous microwave ablation of renal cell carcinoma: practice guidelines of the ultrasound committee of Chinese medical association, interventional oncology committee of Chinese research hospital association.

Yu J, Yu XL, Cheng ZG, Hu B, Han ZY, Liu FY, Hu ZQ, Wang H, Dong J, Pan J, Yang B, Sai X, Guo AT, Liang P. Yu J, et al. Among authors: yu xl. Int J Hyperthermia. 2020;37(1):827-835. doi: 10.1080/02656736.2020.1779356. Int J Hyperthermia. 2020. PMID: 32635839 Free article.

15

SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p.

Liu LX, Liu B, Yu J, Zhang DY, Shi JH, Liang P. Liu LX, et al. Among authors: yu j. Biochem Biophys Res Commun. 2020 Dec 17;533(4):779-785. doi: 10.1016/j.bbrc.2020.09.080. Epub 2020 Sep 26. Biochem Biophys Res Commun. 2020. PMID: 32988587

16

Risk Factor Analysis of Acute Kidney Injury After Microwave Ablation of Hepatocellular Carcinoma: A Retrospective Study.

Yang Y, Liu F, Yu J, Cheng Z, Han Z, Dou J, Hu J, Wang Z, Gao H, Yang Q, Tian J, Xu Y, Bai X, Lu L, Liang P. Yang Y, et al. Among authors: yu j. Front Oncol. 2020 Sep 4;10:1408. doi: 10.3389/fonc.2020.01408. eCollection 2020. Front Oncol. 2020. PMID: 33014779 Free PMC article.

17

Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin-Bilirubin Grade.

Yang H, Cheng Z, Han Z, Liu F, Yu X, Yu J, Liang P. Yang H, et al. Among authors: yu x, yu j. Cardiovasc Intervent Radiol. 2021 Feb;44(2):261-270. doi: 10.1007/s00270-020-02637-9. Epub 2020 Oct 14. Cardiovasc Intervent Radiol. 2021. PMID: 33057809

18

Risk Factors of Ureteral Stenosis After Percutaneous Microwave Ablation of Renal Tumor, a Single-Center Experience.

Wu J, Yu J, Cheng Z, Han Z, Yu X, Li K, Hu P, Liu F, Liang P. Wu J, et al. Among authors: yu x, yu j. Front Oncol. 2020 Sep 18;10:521349. doi: 10.3389/fonc.2020.521349. eCollection 2020. Front Oncol. 2020. PMID: 33072565 Free PMC article.

19

Microwave Ablation Versus Nipple Sparing Mastectomy for Breast Cancer ≤5 cm: A Pilot Cohort Study.

Yu J, Han ZY, Li T, Feng WZ, Yu XL, Luo YC, Wu H, Jiang J, Wang JD, Liang P. Yu J, et al. Among authors: yu xl. Front Oncol. 2020 Oct 7;10:546883. doi: 10.3389/fonc.2020.546883. eCollection 2020. Front Oncol. 2020. PMID: 33117685 Free PMC article.

20

Volume reduction for ≥2 cm benign breast lesions after ultrasound-guided microwave ablation with a minimum 12-month follow-up.

Cui R, Wu H, Xu J, Han Z, Zhang J, Li Q, Dou J, Yu J, Liang P. Cui R, et al. Among authors: yu j. Int J Hyperthermia. 2021;38(1):341-348. doi: 10.1080/02656736.2020.1845401. Int J Hyperthermia. 2021. PMID: 33641568 Free article.

21

Symptomatic aseptic necrosis of benign thyroid lesions after microwave ablation: risk factors and clinical significance.

Dou JP, Yu J, Cheng ZG, Liu FY, Yu XL, Hou QD, Liu F, Han ZY, Liang P. Dou JP, et al. Among authors: yu xl, yu j. Int J Hyperthermia. 2021;38(1):815-822. doi: 10.1080/02656736.2021.1930203. Int J Hyperthermia. 2021. PMID: 34039239 Free article.

22

Percutaneous Microwave Ablation Versus Open Surgical Resection for Colorectal Cancer Liver Metastasis.

Zhao Q, Cheng Z, Han Z, Liu F, Yu X, Tan X, Han B, Dou J, Yu J, Liang P. Zhao Q, et al. Among authors: yu x, yu j. Front Oncol. 2021 May 11;11:638165. doi: 10.3389/fonc.2021.638165. eCollection 2021. Front Oncol. 2021. PMID: 34046342 Free PMC article.

23

Is partial ablation appropriate for benign thyroid nodules? A retrospective study with long-term follow-up after microwave ablation.

Cai W, Liu S, Yu X, Han Z, Cheng Z, Liu F, Yu J, Liang P. Cai W, et al. Among authors: yu x, yu j. Int J Hyperthermia. 2021;38(1):923-930. doi: 10.1080/02656736.2021.1936217. Int J Hyperthermia. 2021. PMID: 34180757 Free article.

24

A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?

Yu J, Wang H, Cheng ZG, Liu FY, Li QY, He GZ, Luo YC, Yu XL, Han ZY, Liang P. Yu J, et al. Among authors: yu xl. Eur Radiol. 2022 Jan;32(1):89-100. doi: 10.1007/s00330-021-07900-2. Epub 2021 Jun 30. Eur Radiol. 2022. PMID: 34195888

25

Ultrasound-guided percutaneous microwave ablation of bilateral renal cell carcinomas: Focus upon safety and efficacy.

Zhang R, Qi E, Liang P, Cheng Z, Tan S, Han Z, Liu F, Yu J, Yu X. Zhang R, et al. Among authors: yu x, yu j. J Cancer Res Ther. 2021 Jul;17(3):803-807. doi: 10.4103/jcrt.jcrt_1906_20. J Cancer Res Ther. 2021. PMID: 34269317 Free article.

26

Microwave ablation of benign thyroid nodules: 3-year follow-up outcomes.

Luo F, Huang L, Gong X, Han Z, Liu F, Cheng Z, Dou J, Yu X, Liang P, Yu J. Luo F, et al. Among authors: yu x, yu j. Head Neck. 2021 Nov;43(11):3437-3447. doi: 10.1002/hed.26842. Epub 2021 Aug 30. Head Neck. 2021. PMID: 34459524

27

Survival benefits analyses of T1a renal cell carcinoma patients treated with microwave ablation.

Hou Q, Yu X, Cheng Z, Han Z, Liu F, Dou J, Yu J, Liang P. Hou Q, et al. Among authors: yu x, yu j. Eur J Radiol. 2021 Nov;144:109951. doi: 10.1016/j.ejrad.2021.109951. Epub 2021 Sep 17. Eur J Radiol. 2021. PMID: 34607288

28

Cause Analysis and Diagnosis and Treatment of Intestinal Fistulas After Ultrasound-Guided Microwave Ablation of Abdominopelvic Lesions.

Tan S, Yu X, Cheng Z, Zhang J, Yu J, Liu F, Gao Y, Linghu R, Han Z, Liang P. Tan S, et al. Among authors: yu x, yu j. Front Surg. 2021 Nov 19;8:675585. doi: 10.3389/fsurg.2021.675585. eCollection 2021. Front Surg. 2021. PMID: 34869548 Free PMC article.

29

Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC.

Wang Z, Liu M, Zhang DZ, Wu SS, Hong ZX, He GB, Yang H, Xiang BD, Li X, Jiang TA, Li K, Tang Z, Huang F, Lu M, Chen JA, Lin YC, Lu X, Wu YQ, Zhang XW, Zhang YF, Cheng C, Ye HL, Wang LT, Zhong HG, Zhong JH, Wang L, Chen M, Liang FF, Chen Y, Xu YS, Yu XL, Cheng ZG, Liu FY, Han ZY, Tang WZ, Yu J, Liang P. Wang Z, et al. Among authors: yu xl, yu j. Hepatology. 2022 Jul;76(1):66-77. doi: 10.1002/hep.32323. Epub 2022 Jan 28. Hepatology. 2022. PMID: 35007334

30

Thermal ablation for papillary thyroid microcarcinoma located in the isthmus: a study with 3 years of follow-up.

Zheng L, Liu FY, Yu J, Cheng ZG, Yu XL, Dong XC, Han ZY, Liang P. Zheng L, et al. Among authors: yu xl, yu j. Future Oncol. 2022 Feb;18(4):471-480. doi: 10.2217/fon-2021-0463. Epub 2022 Jan 20. Future Oncol. 2022. PMID: 35048734

31

CEUS Versus MRI in Evaluation of the Effect of Microwave Ablation of Breast Cancer.

Liu S, Cai W, Luo Y, Dou J, Wu J, Wu H, Han Z, Yu J, Liang P. Liu S, et al. Among authors: yu j. Ultrasound Med Biol. 2022 Apr;48(4):617-625. doi: 10.1016/j.ultrasmedbio.2021.11.012. Epub 2022 Jan 19. Ultrasound Med Biol. 2022. PMID: 35063290

32

Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study.

Yao J, Liu B, Wang X, Yu J, Cheng Z, Han Z, Liu F, Zheng R, Cheng W, Wei Q, Yu S, Li K, Chen P, Luo Y, Yu X, Liang P. Yao J, et al. Among authors: yu s, yu x, yu j. Int J Hyperthermia. 2022;39(1):209-216. doi: 10.1080/02656736.2021.2023228. Int J Hyperthermia. 2022. PMID: 35067144 Free article.

33

Risk factors influencing cure of ultrasound-guided microwave ablation for primary hyperparathyroidism.

Liu F, Zang L, Liu Y, Yu X, Cheng Z, Han Z, Yu J, Liang P. Liu F, et al. Among authors: yu x, yu j. Int J Hyperthermia. 2022;39(1):258-264. doi: 10.1080/02656736.2022.2029957. Int J Hyperthermia. 2022. PMID: 35109732 Free article.

34

Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma.

Wang X, Liang P, Yu J, Yao JD, Fan FY, Yu X, Cheng ZG, Han ZY, Liu FY, Dou JP. Wang X, et al. Among authors: yu x, yu j. Br J Radiol. 2022 May 1;95(1133):20211379. doi: 10.1259/bjr.20211379. Epub 2022 Feb 9. Br J Radiol. 2022. PMID: 35138914 Free PMC article.

35

Comparison of percutaneous microwave ablation and surgical resection for hepatocellular carcinoma in the caudate lobe.

Qi E, Zhang S, Li X, Cheng Z, Han Z, Yu J, Liang P, Yu X. Qi E, et al. Among authors: yu x, yu j. J Cancer Res Ther. 2022 Apr;18(2):378-383. doi: 10.4103/jcrt.jcrt_1067_21. J Cancer Res Ther. 2022. PMID: 35645103 Free article.

36

Percutaneous microwave ablation under ultrasound guidance for renal cell carcinomas at clinical staging T1 in patients aged 65 years and older: A comparative study.

Cheng Z, Yu X, Han Z, Liu F, Yu J, Yang J, Ai D, Liang P. Cheng Z, et al. Among authors: yu x, yu j. J Cancer Res Ther. 2022 Apr;18(2):509-515. doi: 10.4103/jcrt.jcrt_531_22. J Cancer Res Ther. 2022. PMID: 35645122 Free article.

37

Are all local tumour progressions of HCC related to thermal ablation? A study of the causes and classification of local tumour progression.

Ding WZ, Liu S, Liu F, Cheng Z, Yu X, Han ZY, Yu J, Liang P. Ding WZ, et al. Among authors: yu x, yu j. Eur Radiol. 2022 Dec;32(12):8518-8526. doi: 10.1007/s00330-022-08913-1. Epub 2022 Jun 15. Eur Radiol. 2022. PMID: 35704110

38

Predicting ultrasound-guided thermal ablation benefit in primary hyperparathyroidism.

Liu Y, Peng C, Chai H, Yu M, Wu S, Qian L, Han Z, Yu J, Liu F, Liang P. Liu Y, et al. Among authors: yu m, yu j. Eur Radiol. 2022 Dec;32(12):8497-8506. doi: 10.1007/s00330-022-08898-x. Epub 2022 Jun 16. Eur Radiol. 2022. PMID: 35708841

39

Microwave ablation vs. surgery for papillary thyroid carcinoma with minimal sonographic extrathyroid extension: a multicentre prospective study.

Zheng L, Dou JP, Liu FY, Yu J, Cheng ZG, Yu XL, Wang H, Liu C, Yu MA, Cong ZB, Wang SR, Che Y, Xu ZF, Hao Y, Bai N, Wang X, Liu Y, Zhou Y, Shi J, Fu ZH, Zhan HY, Han ZY, Liang P. Zheng L, et al. Among authors: yu xl, yu ma, yu j. Eur Radiol. 2023 Jan;33(1):233-243. doi: 10.1007/s00330-022-08962-6. Epub 2022 Jun 30. Eur Radiol. 2023. PMID: 35771248

40

Prognostic Nutritional Index in Hepatocellular Carcinoma Patients With Hepatitis B Following US-Guided Percutaneous Microwave Ablation: A Retrospective Study With 1,047 Patients.

Wang Y, Li X, Yu J, Cheng Z, Hou Q, Liang P. Wang Y, et al. Among authors: yu j. Front Surg. 2022 Jun 29;9:878737. doi: 10.3389/fsurg.2022.878737. eCollection 2022. Front Surg. 2022. PMID: 35846958 Free PMC article.

41

A Hybrid Machine Learning Model Based on Semantic Information Can Optimize Treatment Decision for Naïve Single 3-5-cm HCC Patients.

Ding W, Wang Z, Liu FY, Cheng ZG, Yu X, Han Z, Zhong H, Yu J, Liang P. Ding W, et al. Among authors: yu x, yu j. Liver Cancer. 2022 Jan 28;11(3):256-267. doi: 10.1159/000522123. eCollection 2022 Jun. Liver Cancer. 2022. PMID: 35949294 Free PMC article.

42

Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience.

Yu J, Cheng ZG, Han ZY, Liu FY, Zheng RQ, Cheng W, Wei Q, Yu SY, Li QY, He GZ, Luo YC, Yu XL, Liang P. Yu J, et al. Among authors: yu sy, yu xl. Liver Cancer. 2022 Jan 28;11(4):341-353. doi: 10.1159/000522134. eCollection 2022 Jul. Liver Cancer. 2022. PMID: 35978603 Free PMC article.

43

Irreversible electroporation induces CD8⁺ T cell immune response against post-ablation hepatocellular carcinoma growth.

Dai Z, Wang Z, Lei K, Liao J, Peng Z, Lin M, Liang P, Yu J, Peng S, Chen S, Kuang M. Dai Z, et al. Among authors: yu j. Cancer Lett. 2021 Apr 10;503:1-10. doi: 10.1016/j.canlet.2021.01.001. Epub 2021 Jan 11. Cancer Lett. 2021. PMID: 33444692

44

Mannose-Derived Carbon Dots Amplify Microwave Ablation-Induced Antitumor Immune Responses by Capturing and Transferring "Danger Signals" to Dendritic Cells.

Zhou Q, Gong N, Zhang D, Li J, Han X, Dou J, Huang J, Zhu K, Liang P, Liang XJ, Yu J. Zhou Q, et al. Among authors: yu j. ACS Nano. 2021 Feb 23;15(2):2920-2932. doi: 10.1021/acsnano.0c09120. Epub 2021 Feb 1. ACS Nano. 2021. PMID: 33523631

45

Review of clinical tumor ablation advance in Asia.

Wang L, Xu J, Yu J, Liang P. Wang L, et al. Among authors: yu j. Int J Hyperthermia. 2021;38(1):1639-1649. doi: 10.1080/02656736.2021.1983037. Int J Hyperthermia. 2021. PMID: 34781824 Free article.

46

Reply.

Wang Z, Yu J, Liang P. Wang Z, et al. Among authors: yu j. Hepatology. 2022 Jul;76(1):E22. doi: 10.1002/hep.32402. Epub 2022 Mar 15. Hepatology. 2022. PMID: 35138652 No abstract available.

47

Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study.

Liu F, Liu Y, Peng C, Yu M, Wu S, Qian L, Han Z, Yu J, Chai H, Liang P. Liu F, et al. Among authors: yu m, yu j. Eur Radiol. 2022 Nov;32(11):7743-7754. doi: 10.1007/s00330-022-08851-y. Epub 2022 May 20. Eur Radiol. 2022. PMID: 35593958

48

Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression.

Cui R, Wang L, Zhang D, Zhang K, Dou J, Dong L, Zhang Y, Wu J, Tan L, Yu J, Liang P. Cui R, et al. Among authors: yu j. Acta Pharm Sin B. 2022 Sep;12(9):3475-3485. doi: 10.1016/j.apsb.2022.05.026. Epub 2022 May 29. Acta Pharm Sin B. 2022. PMID: 36176908 Free PMC article.

49

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma.

Liu L, Liu B, Yu J, Zhang D, Shi J, Liang P. Liu L, et al. Among authors: yu j. Front Mol Biosci. 2021 Sep 21;8:729789. doi: 10.3389/fmolb.2021.729789. eCollection 2021. Front Mol Biosci. 2021. PMID: 34621787 Free PMC article.

50

Physical & Chemical Microwave Ablation (MWA) Enabled by Nonionic MWA Nanosensitizers Repress Incomplete MWA-Arised Liver Tumor Recurrence.

Hou Q, Zhang K, Chen S, Chen J, Zhang Y, Gong N, Guo W, Fang C, Wang L, Jiang J, Dou J, Liang X, Yu J, Liang P. Hou Q, et al. Among authors: yu j. ACS Nano. 2022 Apr 26;16(4):5704-5718. doi: 10.1021/acsnano.1c10714. Epub 2022 Mar 30. ACS Nano. 2022. PMID: 35352557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43,127 results

Search Page